Filter By Cateory

Integrated Physiology of Exocrine and Endocrine Pancreas in Type 1 Diabetes (R01 – Clinical Trial Not Allowed) (RFA-DK-22-022 )

National Institute of Diabetes and Digestive and Kidney Diseases

This Funding Opportunity will support multi-disciplinary teams to examine interactions between exocrine and endocrine pancreas to support the study of T1D. The purpose of this opportunity is to encourage integrated study of the whole pancreas to enable characterization of direct and indirect crosstalk between exocrine and endocrine compartments, and identification of the mechanisms by which that crosstalk occurs and can be disrupted in T1D and other forms of diabetes. Development of assays or platforms to allow for broader investigation into these questions could also be supported.Application due date:

Posted: July 29, 2022
Full grant due: February 22, 2023
Start date: December 2023

HIRN Consortium on Targeting and Regeneration (HIRN-CTAR)(RFA-DK-22-009)

HIRN Consortium on Targeting and Regeneration (HIRN-CTAR) (RFA-DK-22-009)

Purpose: This Funding Opportunity Announcement (FOA) invites applications for the Consortium on Targeting and Regeneration (CTAR) that supports the development of innovative strategies to increase or protect functional human beta cell mass in patients with Type-1 Diabetes (T1D) through controlled manipulation of beta cell replication or islet cell plasticity, reprogramming of non-beta cells into beta-like cells, or shielding of residual beta cell mass from the autoimmune environment. CTAR is part of the Human Islet Research Network (HIRN). Learn more HERE.

Deadlines:
Letter of Intent: September 22, 2022
Application: October 26, 2022
Earliest Start Date: July 2023

Helmsley Charitable Trust’s Type 1 Diabetes (T1D)

A goal of the Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program is to support the discovery and development of interventions to prevent or delay the development of T1D. To address this, the Helmsley T1D Program is pleased to announce a new funding opportunity:  

  • New efforts to understand relationships between the prenatal development period and initiation of islet autoimmunity.

Learn More HERE

Posted: February 1, 2022
Concept notes due: March 15, 2022 
Full grant proposal due: June 1, 2022 
Start date: November 1, 2022 

Helmsley Charitable Trust’s Type 1 Diabetes (T1D)

A goal of the Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program is to support the discovery and development of interventions to prevent or delay the development of T1D. To address this, the Helmsley T1D Program is pleased to announce a new funding opportunity: 

  • New studies into understanding and therapeutically emulating examples where individuals are naturally protected from developing T1D.

Learn More HERE

Posted: February 1, 2022
Concept notes due: March 15, 2022 
Full grant proposal due: June 1, 2022 
Start date: November 1, 2022 

NIH Gateway Award for Collaborative T1D Research (RFA-DK-21-030)

The New Investigator Gateway Award in T1D Research is designed to support a robust pipeline of innovative projects and talented new investigators in T1D research. In addition to providing support for preliminary research, the Gateway program provides an opportunity for new Program Directors/Principal Investigators (PD/PIs) to pursue their studies within the intellectual environment of a select number of large, ongoing collaborative research programs. Embedding awardees within an established scientific framework in each of these consortia will provide unique opportunities for New and Early Stage Investigators to increase their understanding of key questions in the field, to network, and to establish unique and potentially long-lasting collaborations that will propel their careers forward. Bringing New and Early Stage Investigators into existing collaborative research networks will also benefit the networks by providing new ideas and perspectives. Learn more HERE.

Posted: December 3, 2021
Letter of Intent Due: May 1, 2022 and February 20, 2023
Application Due Date: June 1, 2022 and March 20, 2023
Start Date: May 2023 and December 2023

HIRN Catalyst Award (2021)

The Human Islet Research Network (HIRN) announces a new funding initiative to support investigators developing bold, innovative, and challenging projects that will catalyze the field of type 1 diabetes research and provide important advances in topics of interest to the network.

To be considered “catalyzing”, the proposed research must address significant and currently intractable problems by employing approaches or ideas that are currently outside the mainstream of contemporary research. The program is not intended to expand a current research program’s funding in the area of the proposed project, but instead must reflect a fundamental new insight or understanding that will revolutionize the field. Catalyzing advances may emanate from the application of exceptionally innovative approaches and/or from testing
radically unconventional hypotheses.

Click this link to learn more and download the RFP.

Apply HERE

Key Dates:

Posted Date:
Letter of Intent Due Date:
Application Due Date:
Scientific Review:
Start Date:
Expiration Date:

December 1, 2021
March 1, 2022
May 2, 2022
May – June, 2022
August 1, 2022
May 3, 2022

 

Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) (PAR-20-140)

National Institute of Diabetes and Digestive and Kidney Diseases

This Funding Opportunity Announcement (FOA) is intended to support tool or technology development projects, opening new areas of science or translational research. The projects supported by this FOA could involve proof-of-concept studies, prototyping, optimization of a technology for the unique anatomy or physiology of these organ systems, and refinement of technical specifications for subsequent deployment of the technology in laboratory or clinical settings.

Application due date: Standard dates apply
Expiration date: May 8, 2023

Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F31) (PAR-19-378)

National Institute of Diabetes and Digestive and Kidney Diseases

This funding opportunity is to enable promising predoctoral fellows to obtain interdisciplinary training during the dissertation phase of their training from outstanding faculty sponsors in bioinformatics and scientific research relevant to the mission of NIDDK’s Division of Diabetes, Endocrinology and Metabolic Diseases (DDEMD). This training will require mentorship in both bioinformatics and metabolic disease disciplines. In order to advance bioinformatics science and encourage its application to these diseases and disorders, NIDDK invites applications from individuals with novel individual development plans (IDP). The fellowship training plan should focus on interdisciplinary approaches and mentorship among data or computer science and medicine in topics related to diabetes, endocrinology and metabolic diseases.

Application due date: Standard dates apply 
Expiration date: September 8, 2022

Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32) (PAR-19-379)

National Institute of Diabetes and Digestive and Kidney Diseases

This Funding Opportunity Announcement (FOA) is to enable promising postdoctoral fellows to obtain interdisciplinary training from outstanding faculty sponsors in bioinformatics and scientific research relevant to the mission of NIDDK’s Division of Diabetes, Endocrinology and Metabolic Diseases (DDEMD). This training will require mentorship in both bioinformatics and metabolic disease disciplines. In order to advance bioinformatics science and encourage its application to these diseases and disorders, NIDDK invites applications from individuals with novel individual development plans (IDP). The fellowship training plan should focus on interdisciplinary approaches and mentorship among data or computer science and medicine in topics related to diabetes, endocrinology and metabolic diseases.

Application due date: Standard dates apply 
Expiration date: September 8, 2022

Follow
×

Follow

us on our social networks.

Email: hirnec@coh.org